Hovione

    OverviewSuggest Edit

    Hovione is a pharmaceutical company dedicated to helping pharmaceutical customers bring new and off-patent drugs to market. It provides services for the development and compliant manufacture of drugs and supports highly potent compounds. For generic pharmaceutical customers the company offers niche off-patent API products.
    TypePrivate
    Founded1959
    HQLoures, PT
    Websitehovione.com
    Employee Ratings3.7

    Latest Updates

    Employees (est.) (Sept 2021)1,470
    Cybersecurity ratingBMore

    Key People/Management at Hovione

    Marco Gil

    Marco Gil

    Senior Director Commercial Services
    Diane Villax

    Diane Villax

    Founder Chairman of the Board
    Guy Villax

    Guy Villax

    CEO and Director
    Elie Vannier

    Elie Vannier

    Director
    Francisco van Zeller

    Francisco van Zeller

    Director
    Sofia Villax

    Sofia Villax

    Director
    Show more

    Hovione Office Locations

    Hovione has offices in Loures, Lisboa, East Windsor, Mumbai and in 3 other locations
    Ringaskiddy, IE
    Loughbeg
    大阪市, JP
    20F, 阪急グランドビル 8-47
    Lisboa, PT
    Campus do Lumiar, Edifício R, Estrada do Paço do Lumiar
    Luzern, CH
    Pilatusstrasse 23
    East Windsor, NJ, US
    40 Lake Dr
    Show all (9)

    Hovione Financials and Metrics

    Summary Metrics

    Founding Date

    1959

    Hovione Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    89/100

    SecurityScorecard logo

    Hovione Online and Social Media Presence

    Embed Graph

    Hovione News and Updates

    Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

    CORK, Ireland, March 17, 2021 /PRNewswire/ -- Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused by Meibomian Gland Dysfunction (MGD). The well controlled and...

    Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19

    LISBON, Portugal, Sept. 23, 2020 /PRNewswire/ -- Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®. Captisol®, a Ligand product, is a chemically modified cyclodextrin proven to improve the solubility and...

    Hovione Frequently Asked Questions

    • When was Hovione founded?

      Hovione was founded in 1959.

    • Who are Hovione key executives?

      Hovione's key executives are Marco Gil, Diane Villax and Guy Villax.

    • How many employees does Hovione have?

      Hovione has 1,470 employees.

    • Who are Hovione competitors?

      Competitors of Hovione include Johnson Matthey, Wuhan Orient Honest Medical and Impel NeuroPharma.

    • Where are Hovione offices?

      Hovione has offices in Loures, Lisboa, East Windsor, Mumbai and in 3 other locations.

    • How many offices does Hovione have?

      Hovione has 9 offices.